{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Study published by The New England Journal of Medicine finds diabetes drug Jardiance reduces overall risk of having heart attack or stroke, or dying from cardiovascular causes, by 14 percent.", "type_of_material": "News", "word_count": "1133", "lead_paragraph": "In a clinical trial, the drug reduced the risk of having a heart attack or stroke, or of dying from cardiovascular causes by 14 percent.", "pub_date": "2015-09-18T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Jardiance, a Diabetes Drug, Cut Cardiovascular Deaths by 38%, Study Says", "print_headline": "Diabetes Drug Cut Cardiovascular Deaths by 38%, Study Says"}, "snippet": "In a clinical trial, the drug reduced the risk of having a heart attack or stroke, or of dying from cardiovascular causes by 14 percent.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/09/18/business/jardiance-a-diabetes-drug-is-shown-to-reduce-cardiovascular-deaths.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Diabetes", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Heart", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Stroke", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Eli Lilly and Company", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Boehringer Ingelheim GmbH", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Research", "name": "subject"}], "blog": [], "_id": "55fadff838f0d816d1846a7f", "source": "The New York Times"}